Research peptides held in Australian stock, every lot tested by HPLC and mass spectrometry. For laboratory research use only.
Cart 0

Glutathione Side Effects: Safety Findings From Oral, Nebulised and Intravenous Research

Ask what glutathione side effects look like and the honest reply is another question, namely how was it given? Capsules and tablets have a tidy record in randomised trials as long as six months. A nebuliser is another story, because inhaled glutathione tightened the airways of volunteers with mild asthma. Intravenous glutathione sits in between, behaving well in a controlled Parkinson's trial yet harming patients when compounding pharmacies used contaminated powder. Add warnings from Australian, American and Philippine regulators about lightening injections and you have the full picture, which this AminoLab guide unpacks one route at a time.

One molecule, several names

Chemically, glutathione is a tripeptide (glutamate, cysteine, glycine) that our own cells synthesise constantly. GSH, or reduced glutathione, is the working form, and L-glutathione is simply what chemists call the natural isomer. So reduced glutathione side effects and L-glutathione side effects are not two topics at all. Whatever differs between reports comes down to route, amount and product quality. Readers after the biochemistry can start with what glutathione is and how it works.

Summary table of glutathione side effects by route

RouteEvidenceOutcome
OralEuropean Journal of Nutrition 2015, Richie et al., 6 months in 54 adultsHigher blood glutathione with 250 mg and with 1,000 mg daily
OralClinical, Cosmetic and Investigational Dermatology 2017, Weschawalit et al., 12 weeksGood tolerability, nothing serious recorded
Inhaled (nebulised)American Journal of Respiratory and Critical Care Medicine 1997, Marrades et al.Mild asthma group developed bronchoconstriction, cough and breathlessness
Intravenous (trial)Movement Disorders 2009, Hauser et al., 4 weeks in 21 patientsAdverse event rate matched the placebo arm
Intravenous (compounded products)2019 and 2026 FDA alertsShock, fever, chills and sepsis-like illness traced to endotoxin in glutathione powder

Oral trials, where the debate is absorption rather than harm

Richie's group ran the largest controlled oral study to date. Non-smoking adults, 54 of them, were randomised to 250 mg a day, 1,000 mg a day or placebo and followed for half a year without anyone knowing who had what. Stores rose with both amounts in every compartment measured, from erythrocytes and lymphocytes to plasma, and the 1,000 mg arm ended up roughly 30 to 35% above baseline in blood compartments by month six.

Not every team saw a rise. Allen and Bradley (2011, Journal of Alternative and Complementary Medicine) supplied 500 mg twice daily over a four week period, and neither glutathione status nor oxidative stress markers budged. A skin trial by Weschawalit's group had women take 250 mg each day of GSH or of the oxidised form for 12 weeks, and the investigators recorded nothing serious, describing both as well tolerated.

The pattern, then, is reassuring over weeks and months. Researchers argue mostly over whether swallowed glutathione is absorbed intact, not over whether it hurts anyone. The dermatology findings get their own treatment in glutathione for skin and what the lightening studies measured.

Inhaled glutathione, the clearest adverse signal

If one study defines the risk profile, it is the Marrades crossover trial. Eight volunteers with mild asthma inhaled 600 mg of glutathione dissolved in saline on one occasion and placebo on another, double blind and in random order. On glutathione their FEV1 dropped by an average of 19%, airway resistance jumped 61%, and several began coughing or struggling for breath. Those who reacted hardest were also the most sensitive to metabisulfite, so the investigators suspected sulfur-bearing breakdown products.

Reviews that mention nebulised glutathione nearly always cite asthma for exactly this reason.

IV glutathione, a quality problem more than a molecule problem

Hauser's Parkinson's disease trial is the controlled data point. Twenty-one patients had 1,400 mg infusions or placebo three times each week across a month. No participant withdrew over side effects, both arms logged a similar number of events, and the drug did not prove effective.

Every serious IV incident on record involves what was in the bag. Back in 2019, the FDA instructed compounders to quarantine L-glutathione powder from distributor Letco Medical once seven patients had developed reactions that looked like endotoxin exposure, and the agency's own tests found endotoxin well above acceptable limits. The August 2026 alert was larger. At least 30 patients, several admitted to hospital, suffered fever, chills, pain, dizziness, signs of shock and sepsis-like symptoms after IV glutathione made from a single Medisca lot of dietary supplement grade ingredient. The FDA reminded pharmacies that supplement grade inputs have no place in injectable drugs.

That alert is worth remembering. Grade, not chemistry, was what put people in hospital.

Skin lightening injections, the regulator view

  • US FDA (2015). A consumer warning stated that the agency has approved no injectable whitening or lightening drug, that such products commonly contain glutathione, and that they could pose a significant safety risk.
  • Philippine FDA (Advisory 2019-182). The Philippine regulator advised against glutathione injections for lightening, naming potential harm to liver, kidneys and nervous system and the chance of Stevens-Johnson syndrome, and pointed out that published clinical trials of injectable lightening were absent.
  • Australia. Speaking to the ABC in 2020, the Department of Health said the TGA "has not considered the use of glutathione for skin lightening/whitening purposes" and that no one had sought approval for that indication.

Sonthalia and colleagues reached a matching verdict in their 2016 paper for the Indian Journal of Dermatology, Venereology and Leprology. In their reading the mechanism makes sense on paper, but the clinical trials are small and weak, and systemic lightening use cannot be supported until bigger controlled studies exist.

Recurring risk factors in the glutathione side effects record

Personal medical advice is outside what AminoLab provides. Still, four themes come up repeatedly across the papers and alerts above.

  • Asthma combined with nebulised glutathione, from the Marrades data.
  • Dietary supplement grade powder used in injections, from the 2026 FDA alert.
  • Lightening injections with no traceable source, none of which any regulator above has approved.
  • Purity nobody has verified. GSH slowly converts to GSSG once dissolved, so an aged or poorly kept solution no longer contains what the label says.

Personal health questions about glutathione belong with a doctor or pharmacist.

Glutathione at the laboratory bench

Redox signalling, oxidative stress and detoxification enzyme assays all lean on glutathione as an everyday reagent. Our 1,500 mg vial holds reduced L-glutathione, and each lot has been sent to an independent laboratory for mass spectrometry identity testing and HPLC purity testing, with results searchable in our COA lookup. Note that it is not sterile and is not an injectable. Sealed vials belong in a freezer at minus 20 °C, while dissolved material should be refrigerated and finished inside 28 days given how readily GSH oxidises in water. Mitochondrial researchers may also want NAD+ or SS-31, and more options sit among our skin and cellular research compounds.

Buy glutathione in Australia from a tested lot

Nearly every harm described in this guide traces back to an unverified product, and that is the strongest argument for buying from a lot you can check. AminoLab carries one size only, a 1,500 mg reduced glutathione vial, stocked in Australia and ordered online by research laboratories. It is a practical quantity for oxidative stress work at millimolar concentrations, and the independent report for each lot is posted in the COA library. Pair it with NAD+ 500 mg or SS-31 10 mg if your project covers mitochondrial function, and check out in one go.

Sold to adults 18 and over for laboratory research, AminoLab glutathione is never for human or veterinary use.

Frequently Asked Questions

Which glutathione side effects show up in the research?

Route decides it. Swallowed glutathione caused no notable problems in randomised trials lasting up to half a year. Inhaled glutathione triggered airway narrowing in mild asthma. Intravenous glutathione behaved well in a controlled trial, while contaminated compounded batches caused fever, chills and sepsis-like illness in cases the US FDA documented.

Is reduced glutathione safer than L-glutathione, or vice versa?

Neither, because they are the same substance. L-glutathione is the name of the natural isomer and reduced glutathione (GSH) describes it in its active state. When studies report different effects, the cause is the route, the amount or the product quality.

What do regulators say about lightening injections containing glutathione?

They advise against them. The US FDA has never approved an injectable lightening drug. The Philippine FDA named possible liver, kidney and nervous system harm along with Stevens-Johnson syndrome. In Australia the TGA has not considered glutathione for skin lightening at all, and no published trial has shown the practice is safe.

Which practices does the glutathione safety literature flag?

Inhaling glutathione when asthma is present, based on a 1997 trial. Using supplement grade glutathione in anything injected, based on FDA alerts from 2019 and 2026. And lightening injections whose origin cannot be traced. Anyone with a personal health question should ask a doctor or pharmacist.

Does AminoLab sell research glutathione online?

Yes, in a single 1,500 mg vial of reduced GSH, dispatched from stock in Australia. An independent laboratory tests every batch for identity and purity, and the matching report sits in our COA library under the vial's printed number. The vial is non-sterile, not for injection, and supplied for laboratory research only.

Popular Research Peptides

BPC-157

10 mg vial, 60 capsules

From $69

GHK-Cu

50 mg vial, 100 mg vial

From $49

Bacteriostatic Water

3 mL, 3 mL + 1 syringe, 10 mL, 10 mL + 1 syringe, 30 mL, 30 mL + 1 syringe

From $9
Certificate of analysisEvery research peptide comes with the certificate for its lot, listed in the COA library.
Tested identity and purityIdentity confirmed by mass spectrometry and purity measured by HPLC on every batch.
Australian stockOrders pack and ship from Australia with tracked Australia Post delivery. See delivery information.
Adults 18+ onlySold for laboratory research use only, under our research use policy.

Research use onlyAminoLab supplies research compounds for laboratory and in-vitro use, not for human or animal consumption. By continuing you confirm you are 18 or older and buying for research.

Leave